Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
02/2004
02/03/2004US6686351 Compounds and methods for modulation of estrogen receptors
02/03/2004US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents
02/03/2004CA2355987C Bicyclic amide derivatives and their use as muscle relaxants
02/03/2004CA2176741C The preparation of caprolactam
01/2004
01/29/2004US20040019117 Anti tubercular drug: compostions and methods
01/28/2004EP1384713A1 4-amino-azepan-3-one derivatives as protease inhibitors
01/28/2004EP1383748A2 Novel compounds and compositions as cathepsin inhibitors
01/28/2004EP1383741A2 Process for the preparation of benazepril
01/28/2004CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
01/27/2004US6683180 Method for the production of caprolactam
01/27/2004US6683179 Catalytically reacting 6-aminocapronitrile and water in the gas phase, removing ammonia from the resulting mixture of caprolactam, water, high-and low-boiling components, then removing water, then crystallization
01/27/2004US6683178 Preparation of cyclic lactams
01/27/2004US6683177 Catalytic reaction of 6- aminocapronitrile with water and a tetrahydroazepine
01/27/2004US6683075 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
01/27/2004US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists
01/22/2004US20040014965 Obtained by cyclizing hydrolysis of aminonitrile and removal of ammonia by distillation, then crystallization
01/21/2004EP1381668A1 Compounds, compositions, and methods for controlling biofilms
01/20/2004US6680314 Azacyclooctane and heptane derivatives, their preparation and use in therapy
01/15/2004WO2004005256A2 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors
01/15/2004US20040010139 Using iridium complex as hydrogenation catalyst
01/13/2004US6677449 Preparation of caprolactam
01/13/2004US6677448 Treating catalyst, which comprises solid oxide, at temperature of between 300 degrees c. and 600 degrees c. in oxidizing atmosphere
01/13/2004US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus
01/08/2004WO2004002549A1 Use of organic compounds
01/08/2004WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors
01/08/2004WO2003076429A3 Azepane derivatives and their use as atk1 inhibitors
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004CA2490811A1 Use of organic compounds
01/08/2004CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
01/07/2004EP1377543A1 Oxalic acid derivatives
01/07/2004EP1033988B1 Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose
01/06/2004US6673920 Method for the production of N-alkenyl-amides
01/02/2004EP1375482A1 Benzamidine derivative
01/01/2004US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents
01/01/2004US20040002486 Antiproliferative agent
12/2003
12/31/2003WO2003078358A3 Use of microfabricated devices for radiosynthesis
12/30/2003US6670472 Reacting 10-methoxyiminostilbene with cyanic acid (HOCN) in a solvent therefor in the presence of a mild acidic reagent to produce 10-methoxycarbamazepine
12/25/2003US20030236249 Prevent binding to chemokines
12/24/2003WO2003106414A2 Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
12/24/2003WO2003105857A1 Anti-inflammatory compositions and methods of use
12/24/2003CA2486560A1 Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
12/23/2003US6667305 Alzheimer's disease; beta-amyloid peptide is a small fragment of the amyloid precursor protein
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain
12/18/2003WO2003103662A2 Inhibitors of glycoprotein vi
12/18/2003WO2003074474A3 Multiple-component solid phases containing at least one active pharmaceutical ingredient
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/16/2003US6664250 Lactam derivatives as antiarrhythmic agents
12/16/2003US6664249 Bicyclic vasopressin agonists
12/16/2003CA2248407C Thermally stable aminosulfur trifluorides
12/11/2003WO2003045909A3 Methods and intermediates for the synthesis of azepines
12/11/2003WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/10/2003EP1369413A1 Process for producing lactam
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1368322A2 New crystal forms of oxcarbazepine and processes for their preparation
12/10/2003EP1286963B1 Method for separating ammonia from solutions containing caprolactam and ammonia
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/04/2003WO2003099792A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030224006 A solid phase that is sustained by intermolecular interactions (hydrogen bonding) between two or more independent molecular entities, and at least one entity is a drug; improved drug solublity, stability, bioavailability
12/04/2003CA2486962A1 Compounds
12/03/2003EP1365761A1 Therapeutic combination of amlodipine and benazepril
11/2003
11/27/2003WO2003097163A2 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003WO2003097050A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2002074735A3 Biurethane derivatives
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003CA2486061A1 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2484654A1 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/26/2003CN1458923A Substituted amino-aza-cycloalkanes useful against malaria
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/25/2003US6653303 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
11/20/2003WO2003095428A1 Dopamine receptor modulators as antipsychotic agents
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/18/2003US6649717 Stabilized composition of O- and N-vinyl compounds and use of ammonium salts as stabilizers
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003092698A1 A process for the preparation of benazepril hydrochloride
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2484585A1 A process for the preparation of benazepril hydrochloride
11/12/2003EP1169290B1 Process to separate linear alkyl 5-formylvalerate
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 88